All-active antitumor micelles via triggered lipid peroxidation

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Photodynamic Therapy

Background:

• Traditional nanomedicines face challenges with poor tumor targeting (approx. 1%) due to the enhanced permeability and retention (EPR) effect and low drug loading (<5%).
• Developing nanocarriers that function as both delivery vehicles and active therapeutic agents is crucial for improving efficacy.

Purpose of the Study:

• To engineer an "all-active" nanoplatform that enhances antitumor efficacy by combining drug delivery with intrinsic therapeutic properties.
• To investigate the mechanism of action of these novel nanomicelles, including radical generation, cell cycle arrest, and drug release.

Main Methods:

• Photosensitizer Ce6 was encapsulated within polymeric micelles constructed from unsaturated fatty acids.
• The nanomicelles were characterized for their ability to induce lipid peroxidation, generate reactive oxygen species (ROS), and release Ce6 upon light irradiation.
• Cytotoxicity was evaluated using 4T1 cells, and in vivo antitumor efficacy was assessed in 4T1 tumor-bearing mice.

Main Results:

• Light irradiation of Ce6-loaded micelles induced lipid peroxidation, generating cytotoxic free radicals and aldehydes.
• Aldehydes caused significant G2 cell cycle arrest in 4T1 cells, while radicals provided direct cytotoxicity.
• The peroxidation process triggered on-demand micelle disassembly and rapid Ce6 release.
• All-active micelles demonstrated significantly enhanced cytotoxicity (IC50 = 0.6 ± 0.2 μg/mL) compared to control micelles (IC50 = 3.4 ± 0.5 μg/mL).
• Improved in vivo antitumor efficacy was observed in 4T1 tumor-bearing mice.

Conclusions:

• The developed "all-active" nanomicelles offer a facile and effective strategy to enhance the therapeutic efficacy of photodynamic therapy (PDT) nanomedicine.
• Utilizing biocompatible fatty acids and unsaturated lipids provides a versatile platform applicable to various antitumor drugs.
• This approach overcomes limitations of traditional nanomedicines by improving tumor targeting and drug loading through intrinsic therapeutic functions.